Latest Insmed News & Updates

See the latest news and media coverage for Insmed. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Insmed

Biopharmaceutical company developing therapies for serious diseases

insmed.com
Headquarters
Bridgewater Township, United States
Company type
Public company
Number of employees
1,600–5,000

Latest news about Insmed

Company announcements

  • Insmed

    Insmed presents respiratory portfolio data at ATS 2026

    Includes late-breaking ARIKAYCE Phase 3b ENCORE results, BRINSUPRI analysis, TPIP pharmacokinetics, and grants ATS for bronchiectasis diagnosis.

  • Insmed

    Insmed announces CEDAR study fails endpoints

    Insmed discontinues brensocatib HS program. Safety consistent with prior studies, no new signals. Data shows placebo outperformed treatment arms.

  • Insmed

    Insmed announces positive topline results from Phase 3b ENCORE study

    The study met primary and secondary endpoints, showing improvements in respiratory symptoms and culture conversion rates for ARIKAYCE in MAC lung disease patients. Insmed plans sNDA filing in 2026.

  • Insmed

    Insmed highlights Q4 and full-year 2025 earnings success

    Team's passion and dedication to serving patients with serious diseases drive the achievements.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Insmed

Track Insmed and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Insmed competitors & trending companies

Browse news for competitors to Insmed and other trending companies.